Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA-1 TCR-transduced virus-specific donor T-cells after allogeneic stem cell transplantation for high-risk leukemia
NL-OMON38068Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2013
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in leukemia and hematopoietic malignancies, sponsored by Leiden University Medical Center. Primary endpoints: Acute graft-versus-host disease events, Other adverse events and death and 1 more. Started Sep 2013; status: active, not recruiting.
02
Conditions
leukemiahematopoietic malignancies
Beyond the preview
Go deeper on NL-OMON38068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38068.